Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years

This article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and immunogenicity of the domestic influenza inactivated split vaccine «Flu-M» in immunization of the adult population of 18–60 years old. Low reac...

Full description

Bibliographic Details
Main Authors: I. V. Fel'dblyum, S. D. Novgorodova, G. M. Ignat'ev, S. O. Golodnova, V. P. Trukhin, S. Ya Melnikov
Format: Article
Language:Russian
Published: Numikom LLC 2018-02-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/394
_version_ 1797879587666919424
author I. V. Fel'dblyum
S. D. Novgorodova
G. M. Ignat'ev
S. O. Golodnova
V. P. Trukhin
S. Ya Melnikov
author_facet I. V. Fel'dblyum
S. D. Novgorodova
G. M. Ignat'ev
S. O. Golodnova
V. P. Trukhin
S. Ya Melnikov
author_sort I. V. Fel'dblyum
collection DOAJ
description This article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and immunogenicity of the domestic influenza inactivated split vaccine «Flu-M» in immunization of the adult population of 18–60 years old. Low reactogenicity, high safety profile and immunogenicity of the Flu-M vaccine were determined.
first_indexed 2024-04-10T02:50:59Z
format Article
id doaj.art-5782d9c4bfc84aad9c785ba3252a453b
institution Directory Open Access Journal
issn 2073-3046
2619-0494
language Russian
last_indexed 2024-04-10T02:50:59Z
publishDate 2018-02-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj.art-5782d9c4bfc84aad9c785ba3252a453b2023-03-13T07:43:15ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942018-02-01171202410.31631/2073-3046-2018-17-1-20-24392Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 YearsI. V. Fel'dblyum0S. D. Novgorodova1G. M. Ignat'ev2S. O. Golodnova3V. P. Trukhin4S. Ya Melnikov5ФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава РоссииФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава РоссииФГУП «Санкт-Петербургский НИИ вакцин и сывороток и предприятие по производству бактериальных препаратов» ФМБА РоссииФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава РоссииФГУП «Санкт-Петербургский НИИ вакцин и сывороток и предприятие по производству бактериальных препаратов» ФМБА РоссииФГУП «Санкт-Петербургский НИИ вакцин и сывороток и предприятие по производству бактериальных препаратов» ФМБА РоссииThis article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and immunogenicity of the domestic influenza inactivated split vaccine «Flu-M» in immunization of the adult population of 18–60 years old. Low reactogenicity, high safety profile and immunogenicity of the Flu-M vaccine were determined.https://www.epidemvac.ru/jour/article/view/394вакцина против гриппа флю-мвзрослое население 18–60 летбезопасностьреактогенностьиммуногенность
spellingShingle I. V. Fel'dblyum
S. D. Novgorodova
G. M. Ignat'ev
S. O. Golodnova
V. P. Trukhin
S. Ya Melnikov
Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
Эпидемиология и вакцинопрофилактика
вакцина против гриппа флю-м
взрослое население 18–60 лет
безопасность
реактогенность
иммуногенность
title Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
title_full Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
title_fullStr Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
title_full_unstemmed Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
title_short Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
title_sort evaluation of the reactogenicity safety and immunogenicity of the domestic influenza inactivated split flu m vaccine in immunization adults aged 18 60 years
topic вакцина против гриппа флю-м
взрослое население 18–60 лет
безопасность
реактогенность
иммуногенность
url https://www.epidemvac.ru/jour/article/view/394
work_keys_str_mv AT ivfeldblyum evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years
AT sdnovgorodova evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years
AT gmignatev evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years
AT sogolodnova evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years
AT vptrukhin evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years
AT syamelnikov evaluationofthereactogenicitysafetyandimmunogenicityofthedomesticinfluenzainactivatedsplitflumvaccineinimmunizationadultsaged1860years